Genetic Technologies Limited (ASX:GTG)

Genetic Technologies Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	1.01	1.02	7.85	11.73	20.9	14.21
Short-Term Investments	-	0.02	0.02	0.01	0	0
Cash & Short-Term Investments	1.01	1.04	7.87	11.74	20.9	14.22
Cash Growth	-72.84%	-86.79%	-33.00%	-43.82%	47.04%	550.57%
Accounts Receivable	0.15	0.21	0.19	0.44	0.09	0.04
Other Receivables	-	1.92	1.73	1.98	0.98	0.75
Receivables	0.15	2.13	1.92	2.42	1.07	0.79
Inventory	-	0.21	0.33	0.4	0.08	0.09
Prepaid Expenses	-	0.32	0.38	0.15	0.18	0.1
Other Current Assets	0.59	-	-	0	-	-
Total Current Assets	1.75	3.7	10.5	14.72	22.24	15.19
Property, Plant & Equipment	-	0.26	0.6	0.95	0.64	0.44
Goodwill	-	1.78	3.12	4.51	-	-
Other Intangible Assets	-	0.36	0.52	0.62	-	-
Long-Term Deferred Tax Assets	-	0.08	0.12	-	-	-
Other Long-Term Assets	-	-	-	-	0.1	-
Total Assets	1.75	6.19	14.86	20.8	22.97	15.63

Liabilities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Accounts Payable	2.59	1.46	0.84	1.15	0.27	0.35
Accrued Expenses	-	0.86	1.07	1.47	0.86	0.67
Short-Term Debt	0.5	0.64	-	-	-	-
Current Portion of Leases	-	0.21	0.3	0.26	0.18	0.24
Current Unearned Revenue	0.68	0.74	0.85	0.81	0	-
Other Current Liabilities	0.15	0.29	0.25	0.11	0.1	0.13
Total Current Liabilities	3.92	4.2	3.31	3.81	1.41	1.4
Long-Term Debt	-	-	-	-	-	0.05
Long-Term Leases	-	0.02	0.23	0.39	0.02	0.19
Long-Term Deferred Tax Liabilities	-	0.08	0.12	0.15	-	-
Other Long-Term Liabilities	-	0.06	0.03	0.02	0.01	0
Total Liabilities	3.92	4.36	3.69	4.37	1.44	1.64

Shareholders' Equity

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Common Stock	163.96	163.82	161.34	155.14	153.57	140.11
Retained Earnings	-169.7	-166.38	-156.72	-150.21	-143.08	-136.05
Comprehensive Income & Other	3.58	4.39	6.54	11.5	11.03	9.93
Shareholders' Equity	-2.17	1.83	11.16	16.43	21.53	13.99
Total Liabilities & Equity	1.75	6.19	14.86	20.8	22.97	15.63

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Total Debt	0.5	0.88	0.53	0.65	0.2	0.48
Net Cash (Debt)	0.51	0.16	7.34	11.09	20.7	13.73
Net Cash Growth	-84.67%	-97.76%	-33.86%	-46.41%	50.72%	528.52%
Net Cash Per Share	0.00	0.00	0.07	0.12	0.24	0.33
Filing Date Shares Outstanding	145.42	145.42	115.42	92.34	92.26	82.62
Total Common Shares Outstanding	145.42	132.22	115.42	92.34	90.17	75.14
Working Capital	-2.17	-0.5	7.19	10.91	20.83	13.8
Book Value Per Share	-0.01	0.01	0.10	0.18	0.24	0.19
Tangible Book Value	-2.17	-0.31	7.53	11.3	21.53	13.99
Tangible Book Value Per Share	-0.01	-0.00	0.07	0.12	0.24	0.19
Machinery	-	1.32	1.29	1.29	1.22	1.69

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 28, 2026

Data Sources Report a data error